###begin article-title 0
Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.
###end p 1
###begin p 2
###xml 268 273 <span type="species:ncbi:9606">human</span>
APPL1 is an effector of the small GTPase Rab5. Together, they mediate a signal transduction pathway initiated by ligand binding to cell surface receptors. Interaction with Rab5 is confined to the amino (N)-terminal region of APPL1. We report the crystal structures of human APPL1 N-terminal BAR-PH domain motif. The BAR and PH domains, together with a novel linker helix, form an integrated, crescent-shaped, symmetrical dimer. This BAR-PH interaction is likely conserved in the class of BAR-PH containing proteins. Biochemical analyses indicate two independent Rab-binding sites located at the opposite ends of the dimer, where the PH domain directly interacts with Rab5 and Rab21. Besides structurally supporting the PH domain, the BAR domain also contributes to Rab binding through a small surface region in the vicinity of the PH domain. In stark contrast to the helix-dominated, Rab-binding domains previously reported, APPL1 PH domain employs beta-strands to interact with Rab5. On the Rab5 side, both switch regions are involved in the interaction. Thus we identified a new binding mode between PH domains and small GTPases.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 140 141 140 141 <italic>A</italic>
###xml 167 168 167 168 <italic>P</italic>
###xml 177 178 177 178 <italic>P</italic>
###xml 192 193 192 193 <italic>L</italic>
###xml 225 230 225 230 <italic>et al</italic>
###xml 214 236 214 236 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 242 247 242 247 <italic>et al</italic>
###xml 238 253 238 253 <xref ref-type="bibr" rid="b14">Mao <italic>et al</italic>, 2006</xref>
###xml 402 410 402 410 <xref ref-type="bibr" rid="b10">Li, 1996</xref>
###xml 639 644 635 640 <italic>et al</italic>
###xml 635 650 631 646 <xref ref-type="bibr" rid="b12">Liu <italic>et al</italic>, 2002</xref>
###xml 663 668 659 664 <italic>et al</italic>
###xml 652 674 648 670 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 680 685 676 681 <italic>et al</italic>
###xml 676 691 672 687 <xref ref-type="bibr" rid="b11">Lin <italic>et al</italic>, 2006</xref>
###xml 697 702 693 698 <italic>et al</italic>
###xml 693 708 689 704 <xref ref-type="bibr" rid="b14">Mao <italic>et al</italic>, 2006</xref>
###xml 718 723 714 719 <italic>et al</italic>
###xml 710 729 706 725 <xref ref-type="bibr" rid="b27">Varsano <italic>et al</italic>, 2006</xref>
###xml 740 745 736 741 <italic>et al</italic>
###xml 731 751 727 747 <xref ref-type="bibr" rid="b18">Nechamen <italic>et al</italic>, 2007</xref>
###xml 1213 1218 1209 1214 <italic>et al</italic>
###xml 1202 1224 1198 1220 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
Endocytosis induced by ligand-receptor interaction has been directly linked to signal transduction mediated by Rab5 and its effector APPL1 (Adaptor protein containing PH domain PTB domain and Leucine zipper motif; Miaczynska et al, 2004; Mao et al, 2006). The small GTPase Rab5 is a generally acknowledged prominent regulator of vesicle trafficking enroute from the plasma membrane to early endosomes (Li, 1996), whereas APPL1 (also called DIP13alpha) is identified with signaling pathways of adiponectin, insulin, EGF, follicle stimulating hormone receptor, neurotrophin receptor (TrkA), oxidative stress, and DCC-mediated apoptosis (Liu et al, 2002; Miaczynska et al, 2004; Lin et al, 2006; Mao et al, 2006; Varsano et al, 2006; Nechamen et al, 2007). Within this milieu, APPL1 specifically binds to the GTP-bound, active form of Rab5. In response to extracellular stimuli, Rab5 hydrolyzes its bound GTP, releasing APPL1 from an endocytic structure, and allowing APPL1 to further interact with components of nucleosome remodeling and histone deacetylase complexes. The interaction with Rab5 is essential for APPL1 localization to the endosomes and is indispensable for the functional cycle of APPL1 (Miaczynska et al, 2004).
###end p 4
###begin p 5
###xml 110 111 110 111 <italic>B</italic>
###xml 115 116 115 116 <italic>A</italic>
###xml 127 128 127 128 <italic>R</italic>
###xml 152 153 152 153 <italic>p</italic>
###xml 163 164 163 164 <italic>h</italic>
###xml 220 221 220 221 <italic>p</italic>
###xml 227 228 227 228 <italic>t</italic>
###xml 236 237 236 237 <italic>b</italic>
###xml 262 267 262 267 <italic>et al</italic>
###xml 253 273 253 273 <xref ref-type="bibr" rid="b25">Sakamuro <italic>et al</italic>, 1996</xref>
###xml 279 284 279 284 <italic>et al</italic>
###xml 275 290 275 290 <xref ref-type="bibr" rid="b12">Liu <italic>et al</italic>, 2002</xref>
###xml 303 308 303 308 <italic>et al</italic>
###xml 292 314 292 314 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 394 399 394 399 <italic>et al</italic>
###xml 383 405 383 405 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 528 533 528 533 <italic>et al</italic>
###xml 524 539 524 539 <xref ref-type="bibr" rid="b14">Mao <italic>et al</italic>, 2006</xref>
###xml 573 578 570 575 <italic>et al</italic>
###xml 563 584 560 581 <xref ref-type="bibr" rid="b17">Mitsuuchi <italic>et al</italic>, 1999</xref>
###xml 613 618 610 615 <italic>et al</italic>
###xml 609 624 606 621 <xref ref-type="bibr" rid="b12">Liu <italic>et al</italic>, 2002</xref>
###xml 673 678 670 675 <italic>et al</italic>
###xml 669 684 666 681 <xref ref-type="bibr" rid="b11">Lin <italic>et al</italic>, 2006</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human APPL1, a multidomain protein 709 amino-acid (aa) residues in length contains an amino (N)-terminal BAR (Bin1/Amphiphysin/RVS167) domain and a PH (pleckstrin homology) domain followed by a carboxy (C)-terminal PTB (phosphotyrosine binding) domain (Sakamuro et al, 1996; Liu et al, 2002; Miaczynska et al, 2004). The Rab5-binding site is located in the N-terminal BAR-PH region (Miaczynska et al, 2004), while the C-terminal region is found to interact with a host of other proteins, including the adiponectin receptor (Mao et al, 2006), Akt2/PKBbeta kinase (Mitsuuchi et al, 1999), tumor suppressor DCC (Liu et al, 2002), TrkA, and TrkA interacting protein GIPC1 (Lin et al, 2006).
###end p 5
###begin p 6
###xml 192 197 192 197 <italic>et al</italic>
###xml 185 203 185 203 <xref ref-type="bibr" rid="b4">Farsad <italic>et al</italic>, 2001</xref>
###xml 205 220 205 220 <xref ref-type="bibr" rid="b6">Habermann, 2004</xref>
###xml 808 813 792 797 <italic>et al</italic>
###xml 798 819 782 803 <xref ref-type="bibr" rid="b26">Tarricone <italic>et al</italic>, 2001</xref>
###xml 821 836 805 820 <xref ref-type="bibr" rid="b6">Habermann, 2004</xref>
###xml 1198 1203 1182 1187 <italic>et al</italic>
###xml 1188 1209 1172 1193 <xref ref-type="bibr" rid="b26">Tarricone <italic>et al</italic>, 2001</xref>
###xml 1302 1307 1286 1291 <italic>et al</italic>
###xml 1291 1313 1275 1297 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
Based on aa sequence analysis, BAR domains have been identified in many proteins involved in intracellular trafficking, but sequence homology is low in general among known BAR domains (Farsad et al, 2001; Habermann, 2004). The BAR domain typically contains three long kinked alpha-helices (alpha1, alpha2, and alpha3) that form a well-packed, crescent-shaped, symmetrical, six-helix bundle, side-by-side antiparallel homodimer; a structure proposed to exert its function as a convex membrane-curvature sensor or stabilizer. The concave surface of the BAR dimer is proposed to bind preferentially to a negatively charged, curved membrane largely through electrostatic interactions. Furthermore, some BAR domains have been found to bind to small GTPases, a class of intracellular molecular switches (Tarricone et al, 2001; Habermann, 2004); thus, their membrane association is directly linked to regulation of signal transduction and trafficking. However, currently available structural information suggests that bindings of the BAR domain to GTPases and to membrane lipids are incompatible, because both interactions appear to compete for the same concave surface region of the BAR dimer (Tarricone et al, 2001). The BAR domain of APPL1 is required for Rab5 binding and membrane recruitment (Miaczynska et al, 2004), although the mechanisms remain to be elucidated.
###end p 6
###begin p 7
###xml 271 298 271 298 <xref ref-type="bibr" rid="b22">Rebecchi and Scarlata, 1998</xref>
###xml 510 537 503 530 <xref ref-type="bibr" rid="b22">Rebecchi and Scarlata, 1998</xref>
###xml 1004 1009 990 995 <italic>et al</italic>
###xml 993 1015 979 1001 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 1262 1277 1245 1260 <xref ref-type="bibr" rid="b6">Habermann, 2004</xref>
The PH domain is approximately 100-residue long, and has been identified in over 100 different eukaryotic proteins such as kinases, isoforms of phospholipase C (PLC), GTPases, and their regulators; most of which participate in cell signaling and cytoskeletal regulation (Rebecchi and Scarlata, 1998). Despite their minimal sequence homology, the three-dimensional (3D) structures of PH domains are remarkably conserved. They possess a common core consisting of seven beta-strands and a C-terminal alpha-helix (Rebecchi and Scarlata, 1998). Some PH domains specifically bind to phosphatidylinositol phosphates, suggesting that one possible function of this family is to anchor the host proteins to membranes. PH domains are also suggested to bind to the Gbetagamma complex of the heterotrimeric G protein, protein kinase C, and small GTPases. Nevertheless, none of these functions is absolutely conserved. For instance, the PH domain of APPL1 alone is insufficient for binding to the membrane (Miaczynska et al, 2004). The PH domain immediately follows the C-terminus of the BAR domain; such a BAR-PH motif is essential for Rab5 binding. The same motif has also been found in a homolog Rab5 effector APPL2, centaurin-beta family members, GRAF2, and oligophrenin (Habermann, 2004), but the 3D structure organization of BAR-PH motif and its functional implication remained elusive until now.
###end p 7
###begin p 8
###xml 724 739 724 739 <xref ref-type="bibr" rid="b6">Habermann, 2004</xref>
###xml 142 147 <span type="species:ncbi:9606">human</span>
In order to address the functional roles of the BAR-PH motif in APPL1 and related proteins, we have carried out structure-function studies on human APPL1 and determined the crystal structures of the Rab5-binding region of APPL1 as well as the BAR domain alone. The results show that two BAR-PH molecules form an integrated, symmetric homodimer, and the PH domain has extensive intermolecular interactions with the BAR domain. The BAR dimer of APPL1 has a stronger curvature than other reported BAR structures. Further mutagenesis analyses allowed us to identify the binding sites on both APPL1 and Rab5. In sharp contrast to the presumed conflict between concurrent membrane association and GTPase binding by the BAR dimer (Habermann, 2004), the novel binding mode of the BAR-PH dimer should permit simultaneous interactions with both.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Protein expression and crystallography
###end title 10
###begin p 11
###xml 146 162 146 162 <italic>Escherichia coli</italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 146 162 <span type="species:ncbi:562">Escherichia coli</span>
Recombinant proteins of human APPL1 N-terminal fragments including the BAR (residues 5-265) and BAR-PH domains (residues 5-385) were expressed in Escherichia coli, then purified using His tag affinity chromatography. The samples were crystallized after removing the tag with thrombin, which generated a four-residue (Gly-Ser-His-Met) peptide N-terminal to the native Asp5 residue.
###end p 11
###begin p 12
###xml 162 163 162 163 <sub>1</sub>
###xml 164 165 164 165 <sub>1</sub>
###xml 305 323 305 323 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
The BAR domain crystal diffracted up to 1.8-A resolution on a beamline at the Argonne Advanced Photon Source (APS) synchrotron facility. The crystal belongs to P21212 space group. Phases of the structural factors were determined using the Se-Met-based single-wavelength anomalous dispersion (SAD) method (Supplementary data). There is one APPL1 BAR molecule per asymmetric unit, with approximately41% solvent content. Regions of the N-terminus (up to Thr12), Leu75-Asp79, and C-terminus (i.e., Pro260-Asp265) were missing from the final refined model because of lack of interpretable electron density.
###end p 12
###begin p 13
###xml 110 111 110 111 <sub>1</sub>
###xml 112 113 112 113 <sub>1</sub>
###xml 652 659 640 647 <xref ref-type="table" rid="t1">Table I</xref>
The BAR-PH crystal diffracted to 2.05-A resolution at the synchrotron facility. The crystal also belongs to P21212 space group. There is one APPL1 BAR-PH molecule per asymmetric unit, with approximately45% solvent content. Phases of this crystal form were calculated using a combination of molecular replacement and SAD methods, and further improved with density modification. Regions of N-terminal non-native tripeptide (i.e., Gly-Ser-His), Gly76-Asp78, Asn288-Ser295, and C-terminus (i.e., Ser380-Glu385) lacked interpretable electron density and were omitted from the final refined model. Data collection and refinement statistics are summarized in Table I.
###end p 13
###begin title 14
BAR domain structure and dimerization
###end title 14
###begin p 15
###xml 292 300 272 280 <xref ref-type="fig" rid="f1">Figure 1</xref>
###xml 302 324 282 304 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
From the two crystal forms of APPL1 peptides, we obtained two crystallographically independent BAR domain models. In both cases, the APPL1 BAR domain has three long helices, namely alpha1, alpha2, and alpha3. In addition, the APPL1 BAR domain contains an extra nine-turn alpha-helix, alpha4 (Figure 1; Supplementary Figure 1). The two models could be superimposed onto each other with a moderate, 1.3-A, Calpha-atom root mean square deviation (r.m.s.d.) if flexible terminal and loop regions (i.e., residues 5-18, 75-79, 151-153, and 255-265) were omitted. Thus, the overall structure of the BAR domain remains the same either alone or in the context of BAR-PH motif.
###end p 15
###begin p 16
###xml 157 165 157 165 <xref ref-type="fig" rid="f1">Figure 1</xref>
###xml 486 487 474 475 <sup>2</sup>
###xml 664 665 648 649 <sup>2</sup>
In each of the two crystal forms, two BAR molecules form a tightly packed dimer, which assumes a crescent-like shape, a hallmark of the BAR dimer structure (Figure 1). In the BAR dimer, the helix alpha1 forms an antiparallel helix bundle with its symmetry counterpart, giving shape to the concave surface of the crescent-like dimer. Helix alpha4 packs against alpha3 of the symmetry mate on the convex side of the dimer, and its C-terminus points to the tip of the crescent. Over 4400 A2 solvent accessible surface (SAS) from each protomer is buried in the dimer interface. The addition of each alpha4 helix to the canonical BAR motif results in approximate 1900 A2 buried SAS on the two protomers, corresponding to over 40% of the total buried SAS.
###end p 16
###begin p 17
###xml 654 662 642 650 <xref ref-type="fig" rid="f2">Figure 2</xref>
###xml 749 757 737 745 <italic>in vitro</italic>
###xml 784 789 772 777 <italic>et al</italic>
###xml 776 795 764 783 <xref ref-type="bibr" rid="b1">Carlton <italic>et al</italic>, 2004</xref>
Although the overall folding of APPL1 BAR domain is similar to previously reported BAR domain 3D structures (i.e., arfaptin2, PDB file 1I4T; amphiphysin, 1URU; and endophilin, 1ZWW), those structures are in general more similar to each other than to the APPL1 BAR domain. For instance, using 150 Calpha atoms of the common helical regions, the r.m.s.d. values between the dimer of APPL1 BAR and 1I4T, 1URU, and 1ZWW were 3.7, 3.8, and 4.4 A, respectively, while those among 1I4T, 1URU, and 1ZWW range between 2.4 and 2.6 A. In addition, the APPL1 alpha1 and alpha2 helices lack extensive patches of positively charged aa residues on the concave surface (Figure 2); such patches are thought to be essential for some BAR containing proteins to induce in vitro tubule formation (Carlton et al, 2004).
###end p 17
###begin p 18
###xml 134 149 134 149 <xref ref-type="bibr" rid="b6">Habermann, 2004</xref>
###xml 224 225 224 225 <italic>r</italic>
###xml 225 226 225 226 <sub>C</sub>
###xml 270 271 270 271 <italic>r</italic>
###xml 271 272 271 272 <sub>C</sub>
###xml 285 303 285 303 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 305 327 305 327 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 2</xref>
###xml 361 362 361 362 <italic>r</italic>
###xml 362 363 362 363 <sub>C</sub>
###xml 398 403 398 403 <italic>et al</italic>
###xml 392 409 392 409 <xref ref-type="bibr" rid="b21">Peter <italic>et al</italic>, 2004</xref>
The curvature of the concave face of the BAR dimer is thought to play an important role in membrane bending and/or curvature sensing (Habermann, 2004). We implemented a computing algorithm to calculate the curvature radius (rC) and found that the APPL1 BAR dimer has an rC about 55 A (Supplementary data; Supplementary Figure 2), significantly smaller than the rC values of other BAR dimers (Peter et al, 2004). Thus, the APPL1 BAR dimer has the strongest curvature among known BAR dimer structures.
###end p 18
###begin title 19
Structure of the APPL1 PH domain
###end title 19
###begin p 20
###xml 85 107 85 107 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 3</xref>
###xml 286 308 259 281 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 344 345 309 310 <sub>C</sub>
###xml 973 1002 916 945 <xref ref-type="supplementary-material" rid="S1">Supplementary Figures 1 and 3</xref>
The APPL1 PH domain encompasses residues Asn276-Leu379 and has a typical PH folding (Supplementary Figure 3). The core structure of PH domain consists of a pair of nearly orthogonal beta-sheets of four and three antiparallel beta-strands (beta1-beta2-beta3-beta4 and beta5-beta6-beta7; Supplementary Figure 1). The C-terminal alpha-helix, alphaC, packs against both beta-sheets and contributes to the core of the domain. In the PH domain, connecting loops are named after the preceding beta-strands (e.g., the loop between beta1 and beta2 is called L1, etc). The canonical ligand-binding site is composed of beta1, L1, beta2, L3, and L6 (exemplified in the crystal structure of PLC-delta1, PDB file 1MAI) and, roughly speaking, is confined to a triangular area with L1, L3, and L6 as the three vertices. Some positively charged or polar residues that have been previously identified as critical for lipid binding in this ligand-binding triangle are not conserved in APPL1 (Supplementary Figures 1 and 3), consistent with the fact that APPL1 alone lacks membrane binding ability.
###end p 20
###begin title 21
Packing of the BAR and PH domains
###end title 21
###begin p 22
###xml 214 222 214 222 <xref ref-type="fig" rid="f1">Figure 1</xref>
###xml 557 570 551 564 <xref ref-type="fig" rid="f1">Figures 1B, C</xref>
###xml 575 576 569 570 <xref ref-type="fig" rid="f3">3</xref>
###xml 578 600 572 594 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 3</xref>
###xml 624 626 618 620 <sup>15</sup>
###xml 631 633 625 627 <sup>20</sup>
###xml 878 887 863 872 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 913 916 898 901 <sup>334</sup>
###xml 924 927 909 912 <sup>342</sup>
###xml 1051 1060 1028 1037 <xref ref-type="fig" rid="f3">Figure 3B</xref>
###xml 1132 1133 1109 1110 <sup>2</sup>
###xml 1257 1258 1234 1235 <sup>2</sup>
In our crystal structure of the APPL1 BAR-PH dimer, the two PH domains are located at the opposite ends of the crescent-shaped dimer, and each has fairly extensive contact with the BAR domain of its symmetry mate (Figure 1). The addition of the PH domain expands the BAR dimer in the longest dimension from 140 to 170 A, but hardly changes the height of the dimer (i.e., the dimension along the two-fold axis direction) and its curvature. Using its beta1, beta2, L3, and L7 regions, the PH domain contacts the BAR domain of its symmetry mate in two places (Figures 1B, C and 3; Supplementary Figure 3). First, the motif of D15SPxxR20 (where x stands for any aa residue) at the N-terminal of BAR domain contacts beta1, beta2, and L3 regions of PH domain. For instance, the hydroxyl group of Tyr283 in beta1 forms a 2.6-A hydrogen bond with the backbone carbonyl oxygen of Asp15 (Figure 3A). Second, the conserved D334xxDRRYCF342 motif in the loop L7 of the PH domain is directly in contact with the loop connecting alpha2 and alpha3 in the BAR domain (Figure 3B). The buried SAS from each BAR-PH molecule in the dimer is about 6600 A2. Thus, in the presence of PH domain, the buried SAS is 50% larger than that of the dimer formed by BAR domain alone (4400 A2). The canonical 'ligand'-binding triangle of the PH domain is oriented about 60degrees from the concave side of the BAR dimmer, so that both the PH triangle and BAR concave surface could be brought within the vicinity of a curved membrane simultaneously. Nevertheless, as discussed earlier, key residues for lipid interaction are not conserved in APPL1. The C-terminus of PH is exposed to solvent in the dimer, consistent with the fact that it connects to the C-terminal region including the PTB domain.
###end p 22
###begin p 23
###xml 36 38 36 38 <sup>15</sup>
###xml 43 45 43 45 <sup>20</sup>
###xml 477 479 477 479 <sub>10</sub>
###xml 487 496 487 496 <xref ref-type="fig" rid="f3">Figure 3C</xref>
###xml 938 960 922 944 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 1412 1421 1376 1385 <xref ref-type="fig" rid="f3">Figure 3C</xref>
Because of the interaction between D15SPxxR20 motif and PH domain, the rest N-terminus peptide (residues 5-12) clearly became ordered in the BAR-PH crystal structure, in comparison to the BAR domain-alone crystal structure, where residues N-terminal to Leu13 were invisible in the electron density map. The fixed N-terminal peptide in the BAR-PH structure has an extended backbone conformation between Met4 (remnant from the His-tag cleavage) and Pro8, followed by a one-turn 310 helix (Figure 3C). This region has several important intramolecular contacts mainly with helices alpha1 and alpha3. For instance, the Leu7 side chain inserts between the aromatic rings of Phe26 in alpha1 and Phe182 in alpha3. Meanwhile, the side chain of Asn186 forms two hydrogen bonds with the backbone amide and carbonyl groups of Leu7, respectively. All these hydrophobic and hydrogen bond interactions appear conserved among BAR-PH containing proteins (Supplementary Figure 1). Furthermore, the N-terminus is surrounded by a number of regions from the dimer partner, including the helix alpha4 and flexible loop connecting alpha1 and alpha2 (where residues 76-78 were mobile in the crystal structure). For instance, Lys6' (where the prime stands for the dimer partner) forms a salt bridge with Asp243 in alpha4 between the protomers. In addition, Ile9' forms hydrophobic interactions with Met247, Ile251, and Leu254 in alpha4 (Figure 3C).
###end p 23
###begin p 24
###xml 260 269 257 266 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 558 565 555 562 <italic>E. coli</italic>
###xml 894 895 891 892 <italic>k</italic>
###xml 895 896 892 893 <sub>d</sub>
###xml 929 930 926 927 <italic>k</italic>
###xml 930 931 927 928 <sub>d</sub>
###xml 942 960 938 956 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 558 565 <span type="species:ncbi:562">E. coli</span>
To investigate roles of the BAR-PH interaction in solution, a double point mutation, S16E/P17E, at the BAR-PH interface was made. These residues are located in the region N-terminal to the BAR domain and form close contacts with beta2 and L3 of the PH domain (Figure 3A). The recombinant protein of S16E/P17E double mutant in the context of BAR-PH was expressed predominantly in the insoluble fraction of cell lysate; however, the same mutations behaved normal in the BAR-only construct (data not shown). Moreover, expression of the APPL1 PH domain alone in E. coli did not produce soluble recombinant protein. The data suggest that the dimer interaction between PH and BAR domains is critical for the solubility and stability of the APPL1 PH domain. Consistent with this, our analytical ultracentrifugation (AUC) data showed that BAR-PH protein has a higher dimerization affinity in solution (kd=0.34 nM) than BAR domain alone (kd=0.13 muM; Supplementary data).
###end p 24
###begin title 25
APPL1-Rab5 interaction in solution
###end title 25
###begin p 26
###xml 70 71 70 71 <italic>S</italic>
###xml 324 332 324 332 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 641 649 641 649 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 827 832 827 832 <italic>et al</italic>
###xml 816 838 816 838 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 1034 1042 1034 1042 <xref ref-type="fig" rid="f4">Figure 4</xref>
To study APPL1-Rab5 interaction in solution, we performed glutathione S-transferase (GST)-mediated pull-down assays. The APPL1 BAR-PH domain (residues 5-385) and a longer fragment with a 40-residue extension downstream of the PH domain, APPL1 (5-419), were each effectively pulled down by GTP-bound GST-Rab5 fusion protein (Figure 4). The APPL1 protein was pulled down by either WT Rab5 preloaded with non-hydrolysable GTP analog (GppNHp) or Rab5-Q79L defective in GTP hydrolysis (with or without preloaded GTP analog), but could not be effectively pulled down by either the WT Rab5 preloaded with GDP or Rab5-S34N defective in GTP binding (Figure 4 and data not shown). In contrast to the BAR-PH domain, we confirmed that APPL1 BAR domain alone (residues 5-265) cannot directly interact with Rab5 (data not shown) (Miaczynska et al, 2004). Furthermore, using different Rab5 truncation variants, we demonstrated that the N-terminus (residues 1-15) and C-terminus (residues 185-215) of Rab5 are dispensable for interaction with APPL1 (Figure 4).
###end p 26
###begin p 27
###xml 290 312 289 311 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 4</xref>
###xml 342 343 341 342 <italic>k</italic>
###xml 343 344 342 343 <sub>d</sub>
###xml 434 435 430 431 <italic>k</italic>
###xml 435 437 431 433 <sub>on</sub>
###xml 442 443 438 439 <italic>k</italic>
###xml 443 446 439 442 <sub>off</sub>
###xml 467 468 461 462 <sup>3</sup>
###xml 470 472 464 466 <sup>&#8722;1</sup>
###xml 474 476 468 470 <sup>&#8722;1</sup>
###xml 499 501 491 493 <sup>&#8722;3</sup>
###xml 503 505 495 497 <sup>&#8722;1</sup>
###xml 526 527 518 519 <italic>k</italic>
###xml 527 528 519 520 <sub>d</sub>
###xml 607 612 599 604 <italic>et al</italic>
###xml 598 618 590 610 <xref ref-type="bibr" rid="b3">Eathiraj <italic>et al</italic>, 2005</xref>
Binding affinity between full-length Rab5-Q79L and APPL1 (5-419) was quantitatively determined in a surface plasmon resonance (SPR) experiment. Rab5 was coupled to the SPR biosensor chip in random orientations, and APPL1 (5-419) was applied as the analyte at concentrations of 0.15-12 muM (Supplementary Figure 4). The dissociation constant, kd, for the Rab5-APPL1 interaction measured from this experiment was 0.9 (+/-0.7) muM, with kon and koff of 1.3 (+/-0.6) x 103 M-1 s-1, and 1.2 (+/-0.4) x 10-3 s-1, respectively. This kd value is typical for an interaction between a Rab and its effectors (Eathiraj et al, 2005).
###end p 27
###begin title 28
A major Rab5-binding site in the PH domain
###end title 28
###begin p 29
###xml 440 448 440 448 <xref ref-type="fig" rid="f5">Figure 5</xref>
###xml 450 479 450 479 <xref ref-type="supplementary-material" rid="S1">Supplementary Figures 1 and 3</xref>
###xml 695 717 695 717 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 5</xref>
###xml 1118 1125 1118 1125 <italic>E. coli</italic>
###xml 1565 1574 1565 1574 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 1743 1752 1737 1746 <xref ref-type="fig" rid="f5">Figure 5B</xref>
###xml 1754 1776 1748 1770 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 3</xref>
###xml 2056 2065 2050 2059 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 1118 1125 <span type="species:ncbi:562">E. coli</span>
To identify Rab5-binding site(s) in APPL1, GST-Rab5-Q79L (full length) was used to pull down APPL1 variants having surface point mutations. The WT APPL1 (5-419) fragment was used as the parental construct for the mutagenesis, because this fragment is easily distinguishable from GST-Rab5 by size on SDS-PAGE gels without the need for Western blot analysis. A total of 31 point mutations were made at 27 distinct, solvent-exposed positions (Figure 5; Supplementary Figures 1 and 3), based on the structural information of BAR-PH motif. Most of these point mutations were located in the PH domain or near the BAR-PH interface, which are the surface regions most conserved between APPL1 and APPL2 (Supplementary Figure 5). Substitution mutants were designed to maximize potential mutational effects on Rab5 binding (e.g., by flipping charges or switching between hydrophobic and hydrophilic residues) without disrupting the overall structure. In addition, the flexible L1 loop (residues 289-294) was truncated and replaced with one Gly residue. All of these APPL1 variants, as well as the WT construct, were expressed in E. coli, with comparable yields from the soluble fractions (data not shown), in contrast to the mutations at BAR-PH interface mentioned earlier. This suggested that the thirty or so surface mutations had little effect on the stability of BAR-PH dimer. Among them, seven mutants, including V25D, N308D, M310K, A318D, G319R, L321D, and D324A, either abolished or significantly reduced (i.e., retaining <30%) Rab5 binding compared with the WT APPL1 (Figure 5A). In the 3D structure, most of these residues cluster in an elongated surface area formed by beta3, L3, and beta4 of the PH domain, defining a major Rab5-binding site (Figure 5B; Supplementary Figure 3). In addition, the effect of the V25D mutant suggests that the BAR domain also contributes to Rab binding either directly or indirectly. On the other hand, L1 loop seems not to be required for Rab5 binding; significance of the apparent, positive effect of the truncation mutant (Figure 5A) remains to be studied.
###end p 29
###begin p 30
###xml 84 91 84 91 <italic>in vivo</italic>
###xml 439 448 439 448 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 573 582 573 582 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 756 765 756 765 <xref ref-type="fig" rid="f5">Figure 5C</xref>
We further extended these binding studies and confirmed the above Rab5-binding site in vivo in the cell, by monitoring Rab5-mediated APPL1 recruitment to early endosomes in the cell via confocal microscopy. In this case, the RFP (DsRed-monomer)-Rab5-Q79L fusion protein was expressed in PC12 cells, targeted to the early endosomes, and recruited effectively the coexpressed GFP (green fluorescence protein)-APPL1 to these early endosomes (Figure 5C). Importantly, APPL1 (5-385), that is, the BAR-PH domain, was sufficient to target to Rab5-Q79L containing early endosomes (Figure 5C). In contrast, one of the Rab5-binding defective mutants (A318D) failed to target the early endosomes and exhibited a diffused pattern throughout the cytoplasm in the cell (Figure 5C).
###end p 30
###begin p 31
###xml 139 144 139 144 <italic>et al</italic>
###xml 129 150 129 150 <xref ref-type="bibr" rid="b26">Tarricone <italic>et al</italic>, 2001</xref>
Interaction between small GTPase and BAR domain has been exemplified in a complex crystal structure of Rac and arfaptin2 before (Tarricone et al, 2001). Based on the following observations, however, we excluded the possibility of a Rac-arfaptin2-like binding mode for the Rab5-APPL1 interaction. First, the linear dimension of Rab5 is less than 50 A, which is significantly smaller than the distance (approximately60 A) between the putative Rab5-binding site in the PH domain and the central region of the BAR dimmer, where Rac binds with arfaptin2. Second, the isolated APPL1 BAR domain did not bind to Rab5 in our pull-down assay. Third, we mutated APPL1 Asn52, which is at the position equivalent to Rac-binding site in arfaptin2, to either a smaller (Ala) or larger (Arg) side-chain residue, and the mutations showed no effect on the binding to Rab5.
###end p 31
###begin title 32
APPL1 as a Rab21 effector
###end title 32
###begin p 33
###xml 176 205 176 205 <xref ref-type="bibr" rid="b20">Pereira-Leal and Seabra, 2000</xref>
###xml 357 362 357 362 <italic>et al</italic>
###xml 350 368 350 368 <xref ref-type="bibr" rid="b8">Kauppi <italic>et al</italic>, 2002</xref>
###xml 379 384 379 384 <italic>et al</italic>
###xml 370 390 370 390 <xref ref-type="bibr" rid="b3">Eathiraj <italic>et al</italic>, 2005</xref>
###xml 633 641 633 641 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 810 818 810 818 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 852 859 852 859 <italic>in vivo</italic>
###xml 950 957 950 957 <italic>E. coli</italic>
###xml 1338 1346 1338 1346 <xref ref-type="fig" rid="f5">Figure 5</xref>
###xml 1465 1472 1465 1472 <italic>in vivo</italic>
###xml 950 957 <span type="species:ncbi:562">E. coli</span>
Rab5 subfamily contains several members, including Rab5, Rab21, and Rab22. Among them, Rab5 and Rab22 share a higher overall sequence identity with each other than with Rab21 (Pereira-Leal and Seabra, 2000). This difference was used to explain the ability of Rab5 and Rab22, but not Rab21, to share some common effectors such as EEA1 and rabenosyn5 (Kauppi et al, 2002; Eathiraj et al, 2005). Therefore, we tested APPL1 binding specificity towards other members in the Rab5 subfamily, using GST-Rab21 (full length) and GST-Rab22 (2-192) to pull down APPL1 (5-419). Interestingly, APPL1 would bind to Rab21 in a GTP-dependent manner (Figure 4), indicating that APPL1 is an effector for both Rab5 and Rab21. On the other hand, we were unable to detect any binding between APPL1 and Rab22 in the pull-down assay (Figure 4). We could not rule out possible in vivo interaction between them because our recombinant Rab22 might not have folded correctly in E. coli based on the following observations: (1) the expression level of Rab22 was 10- to 20-fold lower than Rab5 and Rab21, and (2) the GTP loading rate of Rab22 was lower too (data not shown). Therefore, we focused our study on Rab5 and Rab21 for their interactions with APPL1. We demonstrated that Rab21 and Rab5 have similar but not identical binding profiles towards APPL1 variants (Figure 5), which may be explained by their sequence divergence. This differential binding to Rab5 and Rab21 by APPL1 may allow in vivo analysis of the functional roles of each Rab-APPL1 interaction, for example, by specifically abolishing one interaction while retaining others.
###end p 33
###begin title 34
A novel Rab effector binding mode between Rab5 and APPL1
###end title 34
###begin p 35
###xml 649 658 649 658 <xref ref-type="fig" rid="f6">Figure 6A</xref>
###xml 744 749 744 749 <italic>et al</italic>
###xml 740 755 740 755 <xref ref-type="bibr" rid="b32">Zhu <italic>et al</italic>, 2004</xref>
###xml 843 852 843 852 <xref ref-type="fig" rid="f6">Figure 6A</xref>
###xml 1121 1126 1121 1126 <italic>et al</italic>
###xml 1112 1132 1112 1132 <xref ref-type="bibr" rid="b15">Merithew <italic>et al</italic>, 2001</xref>
###xml 1225 1230 1225 1230 <italic>et al</italic>
###xml 1221 1236 1221 1236 <xref ref-type="bibr" rid="b32">Zhu <italic>et al</italic>, 2004</xref>
###xml 1247 1252 1247 1252 <italic>et al</italic>
###xml 1238 1258 1238 1258 <xref ref-type="bibr" rid="b3">Eathiraj <italic>et al</italic>, 2005</xref>
###xml 1394 1402 1394 1402 <xref ref-type="fig" rid="f6">Figure 6</xref>
Next we investigated the APPL1-binding regions in Rab5. Since residues responsible for APPL1 binding are likely to be located in the switch I, switch II, and interswitch regions, whose conformations change between different nucleotide binding states, these regions became the main objects of our investigation. In addition to relevant Rab5 mutations that we made in previous studies, several point mutations in the Rab5 switch I region (i.e., residues 40-53) were tested for APPL1 binding. We found that point mutations in the 42-48 region significantly reduced APPL1 binding, while L38R, Q49A, E50A, and I53N showed little or no detectable effect (Figure 6A). Consistent with our previous structural studies on Rab5-rabaptin5 interaction (Zhu et al, 2004), all mutations within the 38-50 region did not interfere with Rab5-rabaptin5 binding (Figure 6A). Furthermore, with the knowledge of crystal structures of Rab5-rabaptin5 and Rab22-rabenosyn5 complexes, it is clear that both Rab5 effectors rabaptin5 and rabenosyn5 bind to the so called invariant hydrophobic triad of Rab5 (i.e., Phe57, Trp74, and Tyr89) (Merithew et al, 2001). Mutation of any of these residues usually strongly inhibits the Rab-effector binding (Zhu et al, 2004; Eathiraj et al, 2005). Interestingly, in our mutagenesis analysis, the APPL1-binding was affected by W74R and Y89R, but not by F57R point mutation in Rab5 (Figure 6). Taken together, our results indicate that APPL1 binds to Rab5 regions including the 40-48 loop and switch II, approximately30 A across. In addition, we showed that the two effectors, APPL1 and rapaptin5, could compete for Rab5-binding (data not shown), confirming that the binding sites of APPL1 and rabaptin5 on the Rab5 surface overlap with each other.
###end p 35
###begin p 36
###xml 507 529 507 529 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 6</xref>
To further define the Rab5-APPL1 binding mode, we performed extensive pull-down analyses between variants of Rab5 and APPL1, looking for reversal mutants that could rescue the lost binding ability of others. We identified one such pair; APPL1-N308D abolished the binding to Rab5, while Rab5-L38R had no effect on APPL1 binding. However, Rab5-L38R was found to bind with APPL1-N308D, but not with the other tested APPL1 variants of similar hydrophobic-to-charged mutations, including V25D, A318D, and L321D (Supplementary Figure 6). This result suggests that Rab5-L38R restores binding for APPL1-N308D through complementary, electrostatic, yet specific interactions. It further implies that the position 308 in the beta3 strand of APPL1 PH domain is in the vicinity of position 38 in the alpha1 helix of Rab5 in their complex.
###end p 36
###begin title 37
Discussion
###end title 37
###begin title 38
BAR-stabilized PH domain is essential for Rab5 binding
###end title 38
###begin p 39
###xml 232 254 232 254 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 419 441 419 441 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 5</xref>
###xml 487 492 487 492 <italic>et al</italic>
###xml 476 498 476 498 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 835 840 835 840 <italic>et al</italic>
###xml 825 846 825 846 <xref ref-type="bibr" rid="b26">Tarricone <italic>et al</italic>, 2001</xref>
Since both APPL1 and APPL2 bind to Rab5, their Rab-binding sites are likely located in a surface region that is conserved between the two APPL proteins. There are no deletion/insertion differences in the BAR-PH region between them (Supplementary Figure 1), and an inspection of the APPL1 BAR-PH dimer surface indicates that the most conserved surface region is located on the PH domain surface and the BAR-PH junction (Supplementary Figure 5). Furthermore, neither PH domain (Miaczynska et al, 2004) nor BAR domain alone (data not shown) can directly bind Rab5, suggesting that the dimer interface between PH and BAR domains plays a critical role in Rab5 binding directly or indirectly. This binding mode between Rab5 and APPL1 is apparently distinct from that between Rac and arfaptin, which only requires BAR dimerization (Tarricone et al, 2001).
###end p 39
###begin p 40
###xml 248 255 248 255 <italic>E. coli</italic>
###xml 442 450 442 450 <italic>in vitro</italic>
###xml 508 516 508 516 <xref ref-type="fig" rid="f5">Figure 5</xref>
###xml 913 918 913 918 <italic>et al</italic>
###xml 902 924 902 924 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 248 255 <span type="species:ncbi:562">E. coli</span>
To investigate further the structural basis of APPL1 and Rab5 interaction, we have performed extensive mutagenesis analyses. A BAR dimer breaking mutant (F210D/F211D) and the BAR-PH interface mutant (S16E/P17E) are both insoluble when expressed in E. coli (data not shown), supporting the notion that the functional form of APPL1 BAR-PH domain is a dimer. Importantly a series of surface point mutants are soluble, allowing us to analyze the in vitro binding properties between these APPL1 mutants and Rab5 (Figure 5). The results indicate that Rab5 specifically binds to the PH domain of APPL1 in the context of BAR-PH dimer, and this binding may marginally extend to the neighboring BAR domain. Our structure-functional analyses are consistent with existing biochemical data. For example, a previously reported triple mutation of APPL1 within the PH domain, K280E/Y283C/G319R, disrupts Rab5 binding (Miaczynska et al, 2004). This effect can be fully explained based on the importance of the BAR-PH and PH-Rab5 interfaces.
###end p 40
###begin p 41
###xml 61 70 61 70 <xref ref-type="fig" rid="f4">Figures 4</xref>
###xml 72 73 72 73 <xref ref-type="fig" rid="f5">5</xref>
###xml 78 79 78 79 <xref ref-type="fig" rid="f6">6</xref>
###xml 132 140 132 140 <xref ref-type="fig" rid="f1">Figure 1</xref>
###xml 232 237 232 237 <italic>et al</italic>
###xml 228 243 228 243 <xref ref-type="bibr" rid="b31">Zhu <italic>et al</italic>, 2003</xref>
###xml 245 249 245 249 <xref ref-type="bibr" rid="b32">2004</xref>
###xml 556 564 556 564 <xref ref-type="fig" rid="f7">Figure 7</xref>
###xml 578 579 578 579 <sup>2</sup>
###xml 1083 1091 1074 1082 <xref ref-type="fig" rid="f6">Figure 6</xref>
###xml 1162 1184 1153 1175 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 6</xref>
###xml 1730 1738 1721 1729 <xref ref-type="fig" rid="f7">Figure 7</xref>
###xml 178 183 <span type="species:ncbi:9606">human</span>
Combined results from our mutagenesis pull-down experiments (Figures 4, 5 and 6), crystal structures of the BAR-PH domain of APPL1 (Figure 1), and structures of GTPase domain of human Rab5 in different nucleotide binding modes (Zhu et al, 2003, 2004) clearly explain the requirement of GTP-bound Rab5 for APPL1 binding. Based on available information, we have modeled the interaction between the two proteins. With the assumption that both proteins remain rigid bodies, our complex model satisfies constraints imposed by the mutagenesis pull-down results (Figure 7). Over 1200 A2 SAS area combined from both the APPL1 dimer and Rab5 would be buried in their interface. In this putative Rab5-APPL1 binding mode, APPL1 interface includes L2, beta3, L3, and beta4 regions. Note that the L3-beta4 region showed weak electron density in the crystal structure, indicating its higher mobility and possible adaptability in forming a complex with Rab5. On the Rab5 side, two regions that harbor binding-defective mutations are involved in the complex formation: the loop 42-48 and switch II (Figure 6). Furthermore, the reversal mutation pair, Rab5-L38R and APPL1-N308D (Supplementary Figure 6) would directly interact with each other inside the interface of our complex model. The bound Rab5 molecules would extend the concave surface of the APPL1 dimer, with both the N- and C-termini of Rab5 exposed to solvent. Considering that there are about 30 residues C-terminal to our Rab5 model, which are necessary for membrane association but excluded from the crystallography study, our model would allow Rab5 molecules to anchor to the membrane through the added C-terminal tails and to interact with APPL1 at both ends of the BAR-PH dimer (Figure 7). The Rab5 C-terminal tail is likely flexible, supporting that recruitment of APPL1 to the endocytic vesicle may not require its direct contact with the membrane. In the complex, the Rab5 molecule does not block the C-terminus of the PH domain, allowing peptide extension of the APPL1 molecule from the BAR-PH domain.
###end p 41
###begin title 42
Rab5-APPL1 interaction represents a novel Rab effector binding mode
###end title 42
###begin p 43
###xml 106 134 102 130 <xref ref-type="bibr" rid="b19">Ostermeier and Brunger, 1999</xref>
###xml 140 145 136 141 <italic>et al</italic>
###xml 136 151 132 147 <xref ref-type="bibr" rid="b32">Zhu <italic>et al</italic>, 2004</xref>
###xml 162 167 158 163 <italic>et al</italic>
###xml 153 173 149 169 <xref ref-type="bibr" rid="b3">Eathiraj <italic>et al</italic>, 2005</xref>
###xml 178 183 174 179 <italic>et al</italic>
###xml 175 189 171 185 <xref ref-type="bibr" rid="b29">Wu <italic>et al</italic>, 2005</xref>
###xml 195 200 191 196 <italic>et al</italic>
###xml 191 206 187 202 <xref ref-type="bibr" rid="b28">Wei <italic>et al</italic>, 2006</xref>
###xml 730 739 717 726 <xref ref-type="fig" rid="f6">Figure 6A</xref>
###xml 745 750 732 737 <italic>et al</italic>
###xml 741 756 728 743 <xref ref-type="bibr" rid="b32">Zhu <italic>et al</italic>, 2004</xref>
In contrast to the alpha-helix dominant Rab-binding motifs of all other effectors of known 3D structures (Ostermeier and Brunger, 1999; Zhu et al, 2004; Eathiraj et al, 2005; Wu et al, 2005; Wei et al, 2006), the Rab5-binding motif of APPL1 is mainly composed of two beta-strands, beta3 and beta4, and their connecting loop L3. Although the exact binding position on the Rab protein and orientation of the effector helices may differ among available complex structures, all these Rab-binding domains interact with the invariant hydrophobic triad. However, we have identified a Rab5 mutation in the hydrophobic triad, F57R, that does not interfere with APPL1 binding, but abolishes the binding to another Rab5 effector, rabaptin5 (Figure 6A; Zhu et al, 2004). In contrast, several point mutations in the switch I region of Rab5 affect the binding of APPL1 but not rabaptin5. The 42-48 region in Rab5 has not been previously reported to be involved in effector binding.
###end p 43
###begin p 44
###xml 91 103 91 103 <xref ref-type="bibr" rid="b9">Lemmon, 2004</xref>
###xml 253 258 253 258 <italic>et al</italic>
###xml 245 264 245 264 <xref ref-type="bibr" rid="b24">Rossman <italic>et al</italic>, 2002</xref>
###xml 266 270 266 270 <xref ref-type="bibr" rid="b23">2003</xref>
###xml 275 280 275 280 <italic>et al</italic>
###xml 272 286 272 286 <xref ref-type="bibr" rid="b13">Lu <italic>et al</italic>, 2004</xref>
###xml 1511 1516 1496 1501 <italic>et al</italic>
###xml 1507 1522 1492 1507 <xref ref-type="bibr" rid="b7">Jin <italic>et al</italic>, 2005</xref>
GTPase binding has emerged as a major function of PH domains in addition to lipid binding (Lemmon, 2004). For example, PH domains in some guanine nucleotide-exchange factors (GEF) have been shown to bind directly to their cognate small GTPases (Rossman et al, 2002, 2003; Lu et al, 2004), and our data now show direct interaction between the APPL1 PH domain and Rab5. So far, only two crystal structures of small GTPase-PH domain complexes are available. One is Ran-RanBD1 (PDB file 1RRP). The interactions between the Ran GTPase domain and RanBD1 PH core domain is fairly minor, occurring between the switch I region of the GTPase (equivalent to the 40's in Rab5) and strand beta2 of the PH domain. This interaction alone is unlikely to be sufficient to form a stable complex. Indeed, Ran has a long C-terminal peptide beside the GTPase domain, while the PH domain of RanBD1 has an extra N-terminal peptide. These two terminal peptides wrap around the partner proteins forming the major interaction between Ran and RanBD1. Such an interaction seems not to be required for Rab5 and APPL1, because the GTPase domain of Rab5 and BAR-PH domain of APPL1 are sufficient to mediate their interaction. The second published small GTPase-PH complex is that of Ral-Exo84 (PDB file 1ZC3). In this complex, the PH domain of Exo84 uses L1, beta5, and L6 to interact with the interswitch and switch II regions of Ral forming an intermolecular beta-sheet extension mediated by the PH beta5 strand and GTPase beta2 strand (Jin et al, 2005). Our mutagenesis analysis points to a different surface region (beta3, L3, and beta4) of the PH domain for Rab5 binding. Therefore, the Rab5-APPL1 interaction represents a new GTPase-PH binding mode.
###end p 44
###begin title 45
APPL1 is a representative of BAR-PH containing proteins
###end title 45
###begin p 46
###xml 252 274 248 270 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 5</xref>
###xml 471 493 467 489 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 495 510 491 506 <xref ref-type="bibr" rid="b6">Habermann, 2004</xref>
###xml 957 959 949 951 <sup>15</sup>
###xml 964 966 956 958 <sup>20</sup>
###xml 972 975 964 967 <sup>334</sup>
###xml 983 986 975 978 <sup>342</sup>
Both APPL1 and APPL2 are identified as Rab5 effectors, and their overall aa sequences are highly homologous. In particular, residues on the APPL1 BAR dimer interface, BAR-PH interface, and the presence of the alpha4 helix seem well conserved in APPL2 (Supplementary Figure 5). Therefore, APPL2 BAR-PH domain most likely forms a homodimer very similar to that of APPL1. Furthermore, these conserved structural features may also extend to other BAR-PH containing proteins (Supplementary Figure 1; Habermann, 2004). For instance, no helix breaking aa sequence appears in the middle of their predicted alpha4 regions. Based on the APPL1 BAR-PH crystal structure, we find that, in general, the PH domain is more conserved than the BAR domain, and most of the highly conserved positions are located closer to the BAR-PH interface rather than the central region of the symmetric dimer. For example, the two major contact regions between PH and BAR domains (i.e., D15SPxxR20 and D334xxDRRYCF342) are conserved at the aa sequence level among BAR-PH containing proteins. In addition, correlated mutations are present between these proteins at the BAR-PH interface. Thus, we propose that all BAR-PH containing proteins share similar 3D structures in the corresponding regions and that the BAR-PH motif may function as a general structural unit to interact with membrane-bound proteins and other molecular moieties.
###end p 46
###begin p 47
###xml 175 180 171 176 <italic>et al</italic>
###xml 169 186 165 182 <xref ref-type="bibr" rid="b21">Peter <italic>et al</italic>, 2004</xref>
###xml 195 200 191 196 <italic>et al</italic>
###xml 188 206 184 202 <xref ref-type="bibr" rid="b5">Gallop <italic>et al</italic>, 2006</xref>
###xml 363 378 359 374 <xref ref-type="bibr" rid="b6">Habermann, 2004</xref>
###xml 638 647 626 635 <xref ref-type="fig" rid="f3">Figure 3C</xref>
###xml 720 742 708 730 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
In some BAR containing proteins, it is proposed that there exists an amphipathic helix N-terminal to the alpha1 helix of BAR domain, and they are called an N-BAR motif (Peter et al, 2004; Gallop et al, 2006). It is suggested that this extra N-terminal region facilitates membrane binding (or bending). A similar N-BAR structure was predicted for APPL1 and APPL2 (Habermann, 2004), but our current APPL1 crystal structure does not show such a structural motif. Instead, the N-terminal region assumes an extended conformation and packs in the groove formed between helices alpha1 and alpha3 on the convex side of the crescent-shaped dimer (Figure 3C). Since the N-terminal regions of the other BAR-PH containing proteins (Supplementary Figure 1) share similar sequences, we suggest that none of these proteins contains an N-BAR motif in their 3D structure.
###end p 47
###begin p 48
###xml 110 132 110 132 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 307 334 304 331 <xref ref-type="bibr" rid="b2">Dinitto and Lambright, 2006</xref>
###xml 336 358 333 355 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
Lacking both the amphipathic helix N-terminal to the BAR domain and the lipid-binding motif in the PH domain (Supplementary Figure 1) may explain the Rab5-dependent membrane association of APPL1. In contrast, the PH domains of centaurin-beta1/2 contain the key, basic residues for phosphoinositide binding (Dinitto and Lambright, 2006; Supplementary Figure 1). If their PH domains are oriented similarly to that in the APPL1 dimer, the canonical (i.e., L1-L3-L6), ligand-binding triangle in their PH domains likely contributes to direct membrane association of these proteins.
###end p 48
###begin title 49
Functional implications of the BAR-PH structure
###end title 49
###begin p 50
###xml 435 440 435 440 <italic>et al</italic>
###xml 424 446 424 446 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
###xml 565 574 557 566 <xref ref-type="fig" rid="f1">Figure 1B</xref>
###xml 613 635 605 627 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
While it is suggested that Rab5-APPL1 interaction mediates a signal transduction pathway between the plasma membrane and the nucleus, the mechanism by which Rab5 binding stimulates APPL1 translocation to the nucleus remains elusive. The current BAR-PH structure may help to clarify the mechanism. Interestingly, the sequence of 'PKKKENE' was identified in the BAR domain of APPL2 as a potential nuclear localization signal (Miaczynska et al, 2004). The corresponding region in APPL1 is the solvent exposed loop connecting alpha2 and alpha3 at the tip of the dimer (Figure 1B) and has a fairly conserved sequence (Supplementary Figure 1). In addition, our preliminary data suggest that there is no detectable binding between the BAR-PH domain and the C-terminal region of APPL1 (data not shown), which makes it unlikely that Rab5 may regulate APPL1 through interference with the intramolecular interaction of the latter. It seems more probable that the Rab5-APPL1 complex recruits downstream effectors to propagate the signal transduction process.
###end p 50
###begin p 51
###xml 397 402 397 402 <italic>et al</italic>
###xml 386 408 386 408 <xref ref-type="bibr" rid="b16">Miaczynska <italic>et al</italic>, 2004</xref>
Unlike other Rab effectors, APPL1/2 proteins function in the signaling pathway from the so-called signaling endosome to nucleus. Our data show that APPL1 interacts with the Rab5 protein using a novel binding mode; it remains to be proven whether such a binding mode is essential for APPL1 function. Whereas it has been shown that APPL1 does not bind other Rab proteins miscellaneously (Miaczynska et al, 2004), we demonstrate that APPL1 is also an effector of Rab21, indicating that APPL1 adopts a binding mode shared by both Rab5 and Rab21. It raises the possibility that, besides Rab5, other members of this Rab subfamily may also be involved in the APPL1 signaling pathway.
###end p 51
###begin title 52
Materials and methods
###end title 52
###begin title 53
Protein expression and purification
###end title 53
###begin p 54
###xml 207 210 207 210 <italic>Nde</italic>
###xml 216 219 216 219 <italic>Bam</italic>
###xml 464 466 464 466 <sup>TM</sup>
###xml 14 19 <span type="species:ncbi:9606">human</span>
Constructs of human APPL1 (GenBank ID: NP_036228) (5-265) (i.e., the BAR domain) and APPL1 (5-385) (i.e., the BAR-PH domain) were inserted into the vectors pET28a and pET15b (Novagen), respectively, between NdeI and BamHI restriction sites. The N-terminal few residues in the native sequence are hydrophobic and were deleted in an attempt to improve the solubility. Point mutations were introduced into the pET15b-APPL1 (5-419) parental construct using QuickChangeTM site-directed mutagenesis kit (Stratagene).
###end p 54
###begin p 55
###xml 114 116 114 116 <sup>TM</sup>
###xml 133 140 133 140 <italic>E. coli</italic>
###xml 223 224 220 221 <sc>D</sc>
###xml 368 370 359 361 <sup>TM</sup>
###xml 491 493 482 484 <sup>TM</sup>
###xml 604 606 583 585 <sup>&#8722;1</sup>
###xml 815 822 782 789 <italic>E. coli</italic>
###xml 898 900 865 867 <sup>&#8722;1</sup>
###xml 133 140 <span type="species:ncbi:562">E. coli</span>
###xml 815 822 <span type="species:ncbi:562">E. coli</span>
His-tagged proteins of APPL1 (5-265) and APPL1 (5-385) were expressed as soluble recombinant proteins in BL21 StarTM (DE3) strain of E. coli (Invitrogen), and cells were harvested after induction with 0.1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) for 8 h at 25degreesC. The cells were lysed with lysozyme, and the lysate supernatant was purified with His-SelectTM affinity beads (Sigma). In both cases, the His tag was removed with thrombin. After further purification with Resource-QTM anion-exchange chromatography (GE Healthcare), both protein samples were concentrated to approximately30 mg ml-1 in (20 mM Tris-HCl (pH 8.0) and 0.1% (v/v) beta-mercaptoethanol (betaME)) and stored at -85degreesC until needed. APPL1 (5-419) mutants were expressed similarly. Se-Met-substituted proteins were expressed in E. coli B834 (DE3) pLysS cells (Novagen) in minimal media supplemented with 40 mg l-1 Se-Met (Sigma) and purified using the same procedure as the native protein.
###end p 55
###begin p 56
###xml 175 182 175 182 <italic>E. coli</italic>
###xml 282 284 270 272 <sup>&#8722;1</sup>
###xml 503 508 482 487 <italic>et al</italic>
###xml 498 514 477 493 <xref ref-type="bibr" rid="b30">Zhai <italic>et al</italic>, 2003</xref>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 175 182 <span type="species:ncbi:562">E. coli</span>
###xml 397 402 <span type="species:ncbi:9606">human</span>
Recombinant proteins of human Rab5a variants (GenBank ID: NM_004162), human Rab21 (BC021901), and human Rab22a (NM_020673) fused with an N-terminal GST were expressed in BL21 E. coli and purified with GST-affinity chromatography. The sample was concentrated to approximately20 mg ml-1 and stored in 1 x phosphate-buffered saline (PBS) with 0.1% (v/v) betaME at -80degreesC. Recombinant protein of human rabaptin5 (551-862) (GenBank ID: CAA62580) was expressed and purified as described previously (Zhai et al, 2003); two additional point mutations, C719S and C734S, were introduced to reduce aggregation.
###end p 56
###begin title 57
Protein crystallization and data collection
###end title 57
###begin p 58
###xml 158 160 152 154 <sup>&#8722;1</sup>
###xml 335 336 326 327 <sub>2</sub>
###xml 338 339 329 330 <sub>4</sub>
Crystals of APPL1 (5-265) were grown at 20degreesC with the hanging drop vapor diffusion method. The Se-Met incorporated protein sample diluted to 10-20 mg ml-1 was mixed 1:1 (v/v) with the reservoir solution of 0.1 M magnesium formate and 0.1% (v/v) betaME. Crystals were transferred to a cryo-protectant solution of (88% saturated Li2SO4, 14 mM magnesium formate, 20 mM Tris-HCl (pH 8.0), and 0.1% (v/v) betaME) by gradually changing the drop solution in 20 min, followed by cooling in liquid nitrogen. A data set was collected at selenium edge at sector 22 BM of the Argonne APS facility.
###end p 58
###begin p 59
Crystals of APPL1 (5-385) were also grown in hanging drops at 20degreesC. The reservoir contained 6% (w/v) polyethylene glycol 6000 (PEG6K), 0.6 M NaCl, and 0.1% (v/v) betaME. The crystals were quickly soaked in a solution of (7.5% (w/v) PEG6K, 0.25 M NaCl, and 10% (v/v) glycerol) and flash-cooled under liquid nitrogen. Both native and SAD data sets were collected at the APS facility. Analyzing the crystal content by SDS-PAGE confirmed the integrity of the protein sample. All data were processed with the program suite HKL2000.
###end p 59
###begin title 60
Pull-down assay for analyzing protein-protein interactions
###end title 60
###begin p 61
###xml 294 295 286 287 <sub>2</sub>
###xml 874 875 826 827 <sub>2</sub>
###xml 1341 1349 1292 1300 <xref ref-type="fig" rid="f5">Figure 5</xref>
In the Rab5-APPL1 pull-down experiment, 30 mug GST-Rab fusion protein (52 kDa) was incubated with 60 mul of 30% slurry of GSH-Sepharose 4B (GE Healthcare) at 22degreesC for 30 min. Nucleotide loading reaction was performed on the GSH beads in an exchange buffer of (1 x PBS, 2 mM DTT, 1 mM MgCl2, 4 mM EDTA, and 400 muM GppNHp or GDP) at 22degreesC for 30 min. Increasing the magnesium ion concentration to 20 mM terminated the loading reaction. Soluble fractions of cell lysate containing all His-tagged APPL1 (5-419) variants were analyzed by SDS-PAGE to confirm their comparable expression level and solubility. The GSH resin carrying nucleotide-loaded GST-Rab fusion protein was incubated with approximately50 mul cell lysate (approximately200 mug APPL1 variant, 50 kDa) at 22degreesC for 30 min, then washed three times with 200 mul of (1 x PBS, 2 mM DTT, and 4 mM MgCl2) and resuspended in 20 mul of 2 x reducing SDS sample buffer. The sample was subjected to SDS-PAGE analysis, visualized with Coomassie blue stain. The same samples were analyzed with chemiluminescence Western blot (GE Healthcare) and His-tag antibody then detected on films which were semi-quantified using the computer software ImageJ () including its default calibration. The relative band intensity of each mutant versus WT from multiple experiments is shown in Figure 5.
###end p 61
###begin title 62
Coordinate deposit
###end title 62
###begin p 63
Coordinates and the structural factors of the APPL1 crystal structures have been deposited to PDB under codes 2Q12 (BAR domain structure) and 2Q13 (BAR-PH domain structure).
###end p 63
###begin title 64
Supplementary Material
###end title 64
###begin p 65
Supplementary Information
###end p 65
###begin p 66
We thank Drs YQ Chen and H Chial of Wake Forest University for the gift of APPL1 cDNA; X Yu and P Wei for assistance in the AUC experiments; W Li and Y Chen for assistance in the SPR experiments; Z Zhou and M Zhang for technical assistance; Dr T Mather for helpful discussion. This project was supported in part by the Oklahoma Center for the Advancement of Science and Technology (US, grant HR03-147 to XCZ), NIH (US, grant GM074692 to GL), and CAS (China, grant 2006CB911002 to XL).
###end p 66
###begin article-title 67
Sorting nexin-1 mediates tubular endosome-to-TGN transport through coincidence sensing of high- curvature membranes and 3-phosphoinositides.
###end article-title 67
###begin article-title 68
Membrane and juxtamembrane targeting by PH and PTB domains.
###end article-title 68
###begin article-title 69
Structural basis of family-wide Rab GTPase recognition by rabenosyn-5.
###end article-title 69
###begin article-title 70
Generation of high curvature membranes mediated by direct endophilin bilayer interactions.
###end article-title 70
###begin article-title 71
Mechanism of endophilin N-BAR domain-mediated membrane curvature.
###end article-title 71
###begin article-title 72
The BAR-domain family of proteins: a case of bending and binding?
###end article-title 72
###begin article-title 73
Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to the RalA GTPase.
###end article-title 73
###begin article-title 74
The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking.
###end article-title 74
###begin article-title 75
Pleckstrin homology domains: not just for phosphoinositides.
###end article-title 75
###begin article-title 76
Rab5 GTPase and endocytosis.
###end article-title 76
###begin article-title 77
APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction.
###end article-title 77
###begin article-title 78
Mediation of the DCC apoptotic signal by DIP13 alpha.
###end article-title 78
###begin article-title 79
PH domain of ELMO functions in trans to regulate Rac activation via Dock180.
###end article-title 79
###begin article-title 80
APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function.
###end article-title 80
###begin article-title 81
Structural plasticity of an invariant hydrophobic triad in the switch regions of Rab GTPases is a determinant of effector recognition.
###end article-title 81
###begin article-title 82
APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment.
###end article-title 82
###begin article-title 83
Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2.
###end article-title 83
###begin article-title 84
APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex.
###end article-title 84
###begin article-title 85
Structural basis of Rab effector specificity: crystal structure of the small G protein Rab3A complexed with the effector domain of rabphilin-3A.
###end article-title 85
###begin article-title 86
The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily.
###end article-title 86
###begin article-title 87
BAR domains as sensors of membrane curvature: the amphiphysin BAR structure.
###end article-title 87
###begin article-title 88
Pleckstrin homology domains: a common fold with diverse functions.
###end article-title 88
###begin article-title 89
Multifunctional roles for the PH domain of Dbs in regulating Rho GTPase activation.
###end article-title 89
###begin article-title 90
A crystallographic view of interactions between Dbs and Cdc42: PH domain-assisted guanine nucleotide exchange.
###end article-title 90
###begin article-title 91
BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.
###end article-title 91
###begin article-title 92
The structural basis of arfaptin-mediated cross-talk between Rac and Arf signalling pathways.
###end article-title 92
###begin article-title 93
GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling.
###end article-title 93
###begin article-title 94
Molecular dissection of Rab11 binding from coiled-coil formation in the Rab11-FIP2 C-terminal domain.
###end article-title 94
###begin article-title 95
Structural basis for recruitment of RILP by small GTPase Rab7.
###end article-title 95
###begin article-title 96
###xml 23 28 <span type="species:ncbi:9606">human</span>
The interaction of the human GGA1 GAT domain with Rabaptin-5 is mediated by residues on its three-helix bundle.
###end article-title 96
###begin article-title 97
###xml 38 43 <span type="species:ncbi:9606">human</span>
High resolution crystal structures of human Rab5a and five mutants with substitutions in the catalytically important phosphate-binding loop.
###end article-title 97
###begin article-title 98
Structural basis of Rab5-Rabaptin5 interaction in endocytosis.
###end article-title 98
###begin p 99
###xml 46 47 46 47 <bold>A</bold>
###xml 399 403 377 381 <bold>B, C</bold>
Crystal structure of the APPL1 BAR-PH dimer. (A) The overall structure of the dimer. The left view is along the direction of the dyad symmetry and on the concave surface, and the right view differs by 90degrees. One protomer is shown in ribbon diagram, and the other is shown in molecular surface model. Helix alpha1 is colored yellow, alpha2 magenta, alpha3 green, alpha4 blue, and PH domain red. (B, C) A close view of the BAR-PH interface. These images were generated using the program PyMol.
###end p 99
###begin p 100
Electrostatic potential distribution of APPL1. Electrostatic potentials of APPL1 BAR-PH protomer (left) and dimer (middle and right) are mapped on their molecular surfaces. Negatively charged regions (-0.5 V) are colored red, positively charged regions (+0.5 V) blue, and neutral regions gray. The right view is looking down along the dyad axis of the dimer at the concave surface, and the side view differs by 90degrees. Clusters of acidic residues which are potentially important in Rab5 binding are circled. This figure was generated with the program CCP4mg.
###end p 100
###begin p 101
###xml 23 27 23 27 <bold>A, B</bold>
###xml 586 608 586 608 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure 1</xref>
###xml 612 613 612 613 <bold>C</bold>
APPL1 domain packing. (A, B), Stereoviews of two major interacting regions between the PH and BAR domains. The PH domain from one APPL1 protomer is colored gray, and the BAR domain from the dimer-mate is colored yellow. Helix backbones are shown in ribbon representation, otherwise in ropes. Side-chain and/or main-chain atoms of selected residues are shown in stick models. Nitrogen atoms are colored blue, oxygen red, and sulfur green. Hydrogen bonds (<3.0 A) are shown as dash-lines. Note that most residues displayed are highly conserved among the known BAR-PH containing proteins (Supplementary Figure 1). (C) Stereoview of interactions of the APPL1 N-terminal region. The two protomers are colored gray and yellow, respectively. This figure was generated with the programs Molscript and Raster3D.
###end p 101
###begin p 102
Pull-down analysis of APPL1-Rab interaction. GST fusion proteins of Rab5, Rab21, and Rab22 were used to pull down His-tagged APPL1 (5-385) and (5-419) fragments in the presence of GDP or GTP analog (GppNHp). The results were analyzed with SDS-PAGE and anti-His Western blot.
###end p 102
###begin p 103
###xml 31 32 31 32 <bold>A</bold>
###xml 423 424 423 424 <bold>B</bold>
###xml 935 936 935 936 <bold>C</bold>
Mutational analyses of APPL1. (A) Quantifying the Rab binding ability of APPL1 variants. The Rab5- and Rab21 binding abilities of APPL1 variants relative to that of WT APPL1 (5-419) were estimated based on chemiluminescence-labeled Western blot (see the Materials and methods) and shown as the white and gray bars, respectively. Standard deviations calculated from multiple experiments were represented by the thin lines. (B) Mutational effects on binding to Rab5 and Rab21. Distribution of point mutations is shown on the molecular surface of the BAR-PH dimer where the two protomers are colored gray and light green, respectively. APPL1 mutations that affect binding strongly (i.e., <30% binding comparing to WT) are colored red; otherwise, the mutants are colored blue. The position showing reversed binding property is colored yellow. Mutation positions are selectively labeled; note that the PH domain contains residues 276-379. (C) Mutational effects on APPL1 targeting to Rab5-positive early endosomes in the cell. RFP-Rab5-Q79L was coexpressed with GFP-APPL1 (full length, FL; BAR-PH domain; or BAR-PH mutant) in PC12 cells as indicated, followed by confocal fluorescence microscopy. Shown are typical confocal microscopic images indicating the RFP-Rab5-Q79L labeled early endosomes (red) and the colocalization of GFP-APPL1 or mutants (green) in the same cells. Scale bar, 16 mum.
###end p 103
###begin p 104
###xml 30 31 30 31 <bold>A</bold>
###xml 215 222 215 222 <italic>E. coli</italic>
###xml 463 464 463 464 <bold>B</bold>
###xml 215 222 <span type="species:ncbi:562">E. coli</span>
Mutational analyses of Rab5. (A) Pull-down assay on Rab5 variants. Point mutations in switch regions were introduced in the full-length Rab5-Q79L background of the GST fusion construct. Each mutant was expressed in E. coli, purified, and equal amounts of each Rab5 sample was used to pull down recombinant proteins of His-tagged WT APPL1 (5-419) (top panel) and His-tagged rabaptin5 (551-862) (bottom panel). The results were visualized by Coomassie blue stain. (B) Molecular surface model of Rab5 GTPase domain. Its N-terminus, switch I (SW1) and switch II (SW2) regions are labeled. Rab5 mutations that have effects and have no effect on binding are labeled red and blue, respectively. The position showing reversed binding property with the APPL1 N308D mutant is colored yellow.
###end p 104
###begin p 105
###xml 60 61 60 61 <bold>A</bold>
###xml 245 254 245 254 <xref ref-type="fig" rid="f5">Figure 5B</xref>
###xml 591 592 591 592 <bold>B</bold>
Putative complex model of the APPL1 BAR-PH dimer and Rab5. (A) APPL1-Rab5 interaction. The two BAR-PH protomers are shown in molecular surface models and colored gray and cyan, respectively. Positions of APPL1 mutations are colored similarly to Figure 5B. Overlaying APPL1, Rab5 is shown in a green backbone trace and positioned according to the mutagenesis data; the N-and C-termini of its GTPase domain are labeled. Rab5 mutants that affect binding are marked with red spheres, and those having no effect are marked with blue spheres. Positions of the reversal mutation pair are labeled. (B) Membrane recruitment of APPL1 mediated by Rab5. The APPL1 BAR-PH protomers are colored gray and yellow, and APPL1 C-terminal peptides are represented by ovals. Rab5 molecules are shown in green molecular surface models, and their membrane anchored C-terminal tails are represented by red curves.
###end p 105
###begin p 106
Crystallography data collection and refinement statistics
###end p 106

